0001567619-22-009611.txt : 20220506 0001567619-22-009611.hdr.sgml : 20220506 20220505162052 ACCESSION NUMBER: 0001567619-22-009611 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 EFFECTIVENESS DATE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-444688 FILM NUMBER: 22896634 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 D 1 primary_doc.xml X0708 D LIVE 0001615219 Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 832-834-6992 DELAWARE None Flex Pharma, Inc. Corporation true David J. Arthur 2540 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Executive Officer Director President, Chief Executive Officer, and Director William K. McVicar 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Chair Tess K. Burleson 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Arnold C. Hanish 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Paul Lammers 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Mark J. Rosenblum 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Executive Officer Executive Vice President and Chief Financial Officer Jonathan Lieber 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Bruce J. McCreedy 2450 Holcombe Blvd. Suite X Houston TX TEXAS 77021 Director Biotechnology Decline to Disclose 06b false 2022-04-25 false true true false 0 Ladenburg Thalmann & Co., Inc. 108604 None None 640 5th Avenue 4th Floor New York NY NEW YORK 10019 All States false 2334859 2334859 0 The warrants and underlying shares of common stock include warrants to purchase 7,004,578 shares of common stock to certain institutional investors. false 4 186789 0 Ladenburg Thalman & Co. Inc. received the above sales commission in connection with the private placement of warrants. 0 false Salarius Pharmaceuticals, Inc. /s/ Mark J. Rosenblum Mark J. Rosenblum Executive Vice President and Chief Financial Officer 2022-05-05